These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4547506)

  • 1. Studies on the interaction of reserpine, d-amphetamine, apomorphine and 5-hydroxytryptophan.
    Goetz C; Klawans HL
    Acta Pharmacol Toxicol (Copenh); 1974 Aug; 35(2):119-30. PubMed ID: 4547506
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonergic and antiserotonergic influences on amphetamine-induced stereotyped behavior.
    Weiner WJ; Goetz C; Westheimer R; Klawans HL
    J Neurol Sci; 1973 Dec; 20(4):373-9. PubMed ID: 4359068
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of caffeine on d-amphetamine- and apomorphine-induced stereotyped behavior.
    Klawans HL; Moses H; Beaulieu DM
    Life Sci; 1974 Apr; 14(8):1493-500. PubMed ID: 4364279
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotonergic and antiserotonergic influences on apomorphine-induced stereotyped behaviour.
    Weiner WJ; Goetz C; Klawans HL
    Acta Pharmacol Toxicol (Copenh); 1975 Feb; 36(2):155-60. PubMed ID: 1079682
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of amantadine and L-dopa on apomorphine- and d-amphetamine-induced stereotyped behaviour in rats.
    Cox B; Tha SJ
    Eur J Pharmacol; 1973 Oct; 24(1):96-100. PubMed ID: 4796449
    [No Abstract]   [Full Text] [Related]  

  • 6. Modification of central serotonergic and dopaminergic behaviors in the course of chronic corticosteroid administration.
    Nausieda PA; Carvey PM; Weiner WJ
    Eur J Pharmacol; 1982 Mar; 78(3):335-43. PubMed ID: 6978254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute increases by p-chlorophenylalanine of apomorphine-induced stereotyped behavior in the rat.
    Baldessarini RJ; Griffith FF
    Psychopharmacology (Berl); 1976 Jul; 48(1):91-5. PubMed ID: 135269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic antagonism of L-5-hydroxytryptophan-induced myoclonic jumping behavior.
    Weiner WJ; Carvey PM; Nausieda PA; Klawans HL
    Neurology; 1979 Dec; 29(12):1622-5. PubMed ID: 41197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of apomorphine and D-amphetamine effects by naloxone.
    Adams PM; Beauchamp R; Alston C
    Life Sci; 1981 Feb; 28(6):629-34. PubMed ID: 7193793
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent.
    Johnson AM; Vigouret JM; Loew DM
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R40. PubMed ID: 4276573
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of apomorphine and its interaction with other drugs in the domestic fowl.
    Osuide G; Adejoh PO
    Eur J Pharmacol; 1973 Jul; 23(1):56-66. PubMed ID: 4739056
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential behavioral responses of spontaneously hypertensive (SHR) and normotensive (WKY) rats to d-amphetamine.
    McCarty R; Chiueh CC; Kopin IJ
    Pharmacol Biochem Behav; 1980 Jan; 12(1):53-9. PubMed ID: 6445066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats.
    Fessler RG; Sturgeon RD; Meltzer HY
    Pharmacol Biochem Behav; 1980 Dec; 13(6):835-42. PubMed ID: 7193876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of withdrawal from chronic amphetamine intoxication on exploratory and stereotyped behaviors in the rat.
    Hitzemann RJ; Tseng LF; Hitzemann BA; Sampath-Khanna S; Loh HH
    Psychopharmacology (Berl); 1977 Nov; 54(3):295-302. PubMed ID: 413148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine.
    Fray PJ; Sahakian BJ; Robbins TW; Koob GF; Iversen SD
    Psychopharmacology (Berl); 1980; 69(3):253-9. PubMed ID: 6774363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of reserpine on concurrent repeated administration of d-amphetamine.
    Dougherty GG; Ellinwood EH
    Psychopharmacology (Berl); 1984; 82(4):327-9. PubMed ID: 6427823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral supersensitivity to 5-hydroxytryptophan induced by chronic methysergide pretreatment.
    Klawans HL; D'Amico DJ; Patel BC
    Psychopharmacologia; 1975 Nov; 44(3):297-300. PubMed ID: 1082146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of clonidine on locomotor activity in mice.
    Maj J; Sowińska H; Baran L; Kapturkiewicz Z
    Life Sci I; 1972 May; 11(10):483-91. PubMed ID: 4676386
    [No Abstract]   [Full Text] [Related]  

  • 19. Supersensitivity to d-amphetamine- and apomorphine-induced stereotyped behavior induced by chronic d-amphetamine administration.
    Klawans HL; Margolin DI; Dana N; Crosset P
    J Neurol Sci; 1975 Jul; 25(3):283-9. PubMed ID: 1171935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of estrogen and progesterone on behavioral effects of apomorphine and amphetamine.
    Michanek A; Meyerson BJ
    Pharmacol Biochem Behav; 1982 Jun; 16(6):875-9. PubMed ID: 7202216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.